Related Experiment Video
Updated: Oct 22, 2025

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
16.9K
HIV/AIDS policy-making in Iran: A stakeholder analysis
Rahim Khodayari-Zarnaq1,2, Hamid Ravaghi3, Ali Mohammad Mosaddegh-Rad4
1Department of Health Policy and Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.
The International Journal of Health Planning and Management
|August 29, 2021
Summary
Iran
Area of Science:
- Public Health
- Health Policy Analysis
- Social Science Research
Background:
- The study addresses the critical need to understand stakeholder involvement in HIV/AIDS control in Iran.
- Identifies key actors and their participation levels in the national HIV/AIDS response.
Purpose of the Study:
- To identify and analyze the diverse stakeholders involved in HIV/AIDS policy and control in Iran.
- To assess the participation and influence of various governmental and non-governmental organizations.
Main Methods:
- A qualitative stakeholder analysis was conducted nationwide in 2018.
- Purposive and snowball sampling methods were employed, with data analyzed using framework analysis.
- MAXQDA and Policy Maker software were utilized for data analysis.
Main Results:
- 44 stakeholders were identified: 23 active and 21 inactive.
- The Ministry of Health (MoH) is the lead stewardship body but lacks sufficient authority.
- Participation levels varied, with some entities showing moderate to low engagement in HIV/AIDS policymaking.
Conclusions:
- HIV/AIDS policymaking in Iran is fragmented, despite numerous stakeholders.
- An integrated system is lacking to effectively involve all relevant parties in HIV/AIDS control efforts.
- An overarching coordinating entity is recommended to enhance stakeholder mobilization and management for HIV/AIDS control.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
493
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
493
International Nursing Organizations I
1.9K
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
1.9K
International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
Drug Control Governance: Regulatory Bodies and Their Impact
298
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
298
Healthcare Associated Infections II: Preventive Measures
3.2K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Retrovirus Life Cycles
47.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.7K

